🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

It’s hard to imagine a more tireless and effective champion for the type 1 diabetes (T1D) community than Senator Jeanne Shaheen. Fueled by the diagnosis of her granddaughter, she has fought relentlessly in Congress alongside her Senate Diabetes Caucus co-chair, Senator Susan

Our Breakthrough T1D Advocacy staff is wrapping up #NationalVolunteerWeek with a big 'thank you' to all of our amazing Advocacy volunteers. We can't thank our volunteers enough for their passion, drive, and dedication to #PoweringT1DBreakthroughs.

ICYMI: Breakthrough T1D thanks Chairwoman Sen. Susan Collins & Ranking Member Senator Patty Murray for their leadership in holding a Senate Appropriations Committee hearing earlier this week titled ‘Biomedical Research: Keeping America's Edge in Innovation.' We submitted a statement to the

Lynn Starr, Chief Global Advocacy Officer, discusses two new Breakthrough T1D papers detailing the significant physical, emotional, and financial burdens of managing type 1 diabetes (T1D), despite advancements in technology and therapies. These findings underscore the urgent need

Through Project Accelerate Cell Therapies, or Project ACT, Breakthrough T1D is pushing for the policies, funding, and access needed to bring manufactured cell therapies to the T1D community and make them available to everyone who needs them. Learn more here:

This week, with the support of other diabetes organizations and clinical experts, Breakthrough T1D submitted an application to the U.S. Preventive Services Task Force (USPSTF) to make screening for type 1 diabetes (#T1D) a recommended preventive service. Why does this matter? A

Yesterday’s Senate Appropriations Committee hearing is yet another example of how our Senate Diabetes Caucus Co-Chairs, Sen. Susan Collins (R-ME) and Sen. Jeanne Shaheen (D-NH) are fighting for millions of Americans with #T1D. Here, Sen. Shaheen and FDA Commissioner Dr. Martin Makary